Neuroblastoma and bone metastases: Clinical significance and prognostic value of Dickkopf 1 plasma levels (Englisch)
- Neue Suche nach: Granchi, D.
- Neue Suche nach: Corrias, M. V.
- Neue Suche nach: Garaventa, A.
- Neue Suche nach: Baglio, S. R.
- Neue Suche nach: Cangemi, G.
- Neue Suche nach: Carlini, B.
- Neue Suche nach: Paolucci, P.
- Neue Suche nach: Giunti, A.
- Neue Suche nach: Baldini, N.
- Neue Suche nach: Granchi, D.
- Neue Suche nach: Corrias, M. V.
- Neue Suche nach: Garaventa, A.
- Neue Suche nach: Baglio, S. R.
- Neue Suche nach: Cangemi, G.
- Neue Suche nach: Carlini, B.
- Neue Suche nach: Paolucci, P.
- Neue Suche nach: Giunti, A.
- Neue Suche nach: Baldini, N.
In:
BONE -NEW YORK-
;
48
, 1
;
152-159
;
2011
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Neuroblastoma and bone metastases: Clinical significance and prognostic value of Dickkopf 1 plasma levels
-
Beteiligte:Granchi, D. ( Autor:in ) / Corrias, M. V. ( Autor:in ) / Garaventa, A. ( Autor:in ) / Baglio, S. R. ( Autor:in ) / Cangemi, G. ( Autor:in ) / Carlini, B. ( Autor:in ) / Paolucci, P. ( Autor:in ) / Giunti, A. ( Autor:in ) / Baldini, N. ( Autor:in )
-
Erschienen in:BONE -NEW YORK- ; 48, 1 ; 152-159
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2011
-
Format / Umfang:8 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.71
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.71 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 48, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
IBMS Elected Board of Directors 2010-2011| 2011
- 2
-
IBMS 2011 Corporate Partners| 2011
- 3
-
IBMS Membership Application| 2011
- 5
-
Foreword: Skeletal Complications of CancerSmith, M. R. / Martin, T. J. et al. | 2011
- 6
-
Advances in the biology of bone metastasis: How the skeleton affects tumor behaviorSterling, J. A. / Edwards, J. R. / Martin, T. J. / Mundy, G. R. et al. | 2011
- 16
-
Dysregulation of developmental pathways in bone metastasisSethi, N. / Kang, Y. et al. | 2011
- 23
-
TGF-b in cancer and bone: Implications for treatment of bone metastasesJuarez, P. / Guise, T. A. et al. | 2011
- 30
-
Metastatic bone disease: Role of transcription factors and future targetsPratap, J. / Lian, J. B. / Stein, G. S. et al. | 2011
- 37
-
Epithelial plasticity, cancer stem cells and bone metastasis formationvan der Pluijm, G. et al. | 2011
- 44
-
Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasisLynch, C. C. et al. | 2011
- 54
-
Integrins and bone metastasis: Integrating tumor cell and stromal cell interactionsSchneider, J. G. / Amend, S. R. / Weilbaecher, K. N. et al. | 2011
- 66
-
The bone remodeling environment is a factor in breast cancer bone metastasisOoi, L. L. / Zheng, Y. / Stalgis-Bilinski, K. / Dunstan, C. R. et al. | 2011
- 71
-
Bisphosphonates' antitumor activity: An unravelled side of a multifaceted drug classClezardin, P. et al. | 2011
- 80
-
Advances in management of bone disease in breast cancerWalkington, L. / Coleman, R. E. et al. | 2011
- 88
-
Treatment and prevention of bone complications from prostate cancerLee, R. J. / Saylor, P. J. / Smith, M. R. et al. | 2011
- 96
-
Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasisLipton, A. / Goessl, C. et al. | 2011
- 100
-
Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone painYoneda, T. / Hata, K. / Nakanishi, M. / Nagae, M. / Nagayama, T. / Wakabayashi, H. / Nishisho, T. / Sakurai, T. / Hiraga, T. et al. | 2011
- 106
-
Optical advances in skeletal imaging applied to bone metastasesSnoeks, T. J. / Khmelinskii, A. / Lelieveldt, B. P. / Kaijzel, E. L. / Lowik, C. W. et al. | 2011
- 115
-
Effects of the bone marrow microenvironment on hematopoietic malignancyAskmyr, M. / Quach, J. / Purton, L. E. et al. | 2011
- 121
-
Tumor-host cell interactions in the bone disease of myelomaFowler, J. A. / Edwards, C. M. / Croucher, P. I. et al. | 2011
- 129
-
TGF-b-related mechanisms of bone destruction in multiple myelomaMatsumoto, T. / Abe, M. et al. | 2011
- 135
-
Osteoblast function in myelomaRoodman, G. D. et al. | 2011
- 141
-
Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destructionJohnson, L. C. / Johnson, R. W. / Munoz, S. A. / Mundy, G. R. / Peterson, T. E. / Sterling, J. A. et al. | 2011
- 152
-
Neuroblastoma and bone metastases: Clinical significance and prognostic value of Dickkopf 1 plasma levelsGranchi, D. / Corrias, M. V. / Garaventa, A. / Baglio, S. R. / Cangemi, G. / Carlini, B. / Paolucci, P. / Giunti, A. / Baldini, N. et al. | 2011
- 160
-
Skeletal complications and survival in renal cancer patients with bone metastasesWoodward, E. / Jagdev, S. / McParland, L. / Clark, K. / Gregory, W. / Newsham, A. / Rogerson, S. / Hayward, K. / Selby, P. / Brown, J. et al. | 2011
- i
-
Editorial Board| 2011
- S4
-
Reactivation of EMT-inducing transcription factors and cancer developmentPuisieux, A. et al. | 2011
- S5
-
Molecular genetics and risk of metastasisLinn, S. C. et al. | 2011
- S6
-
Controversies in the use of bone targeted agents: Breast cancer preventionChlebowski, R. T. et al. | 2011
- S7
-
Bone marrow endothelial cells as active players in the pathobiology of multiple myelomaVanderkerken, K. / De Bruyne, E. / Menu, E. / Van Valckenborgh, E. / Van Camp, B. et al. | 2011
- S8
-
Targeting cancer invasion and metastasisFrame, M. / Serrels, B. / Serrels, A. / Canel, M. / Sandilands, E. / Welman, A. / Brunton, V. et al. | 2011
- S9
-
New therapies for cancer-induced bone disease: Preclinical perspectiveGuise, T. et al. | 2011
- S10
-
Osteoclast-dependent and -independent effects of RANKL inhibition on tumorigenesis and metastasisDougall, B. et al. | 2011
- S11
-
SRC inhibition as an approach to treating tumor-induced bone diseaseBoyce, B. F. et al. | 2011
- S13
-
Identification of plasma biomarkers that predict breast cancer bone metastasisWasham*, C. L. / Byrum, S. D. / Leitzel, K. / Lipton, A. / Suva, L. J. et al. | 2011
- S14
-
TGF-b promotion of GLI2 induced pthrp expression is independent of canonical hedgehog signalingJohnson*, R. W. / Nguyen, M. P. / Padalecki, S. / Grubbs, B. / Merkel, A. R. / Oyajobi, B. / Mundy, G. R. / Sterling, J. A. et al. | 2011
- S15
-
BMP2/7 heterodimeric proteins are potent antagonists of TGFbeta-induced signaling, invasiveness and bone metastasis via inhibition of cancer stem cellsBuijs, J. T. / van der Horst*, G. / van den Hoogen, C. / Petersen, M. / Cheung, H. / de Rooij, B. / Pelger, R. C. / van der Pluijm, G. et al. | 2011
- S16
-
Results of the Medical Research Council (MRC) Myeloma IX study: Effects of zoledronic acid (ZOL) on overall survival (OS) in patients with multiple myeloma (MM)Morgan*, G. J. / Davies, F. E. / Gregory, W. M. / Bell, S. E. / Szubert, A. J. / Navarro Coy, N. / Ashcroft, A. J. / Drayson, M. T. / Owen, R. G. / Jackson, G. H. et al. | 2011
- S18
-
Incidence and outcomes of osteonecrosis of the jaw from an integrated analysis of three pivotal randomized double-blind, double-dummy phase 3 trials comparing denosumab and zoledronic acid for treatment of bone metastases in advanced cancer patients or myelomaBrown*, J. E. / Barrios, C. H. / Diel, I. J. / Facon, T. / Fizazi, K. / Ibrahim, T. / Saad, F. / Senecal, F. / Stemmer, S. M. / Stopeck, A. et al. | 2011
- S19
-
Halofuginone reduces bone metastases: TGF-b-dependent and independent effectsJuarez*, P. / Mohammad, K. / Mckenna, R. / Walton, H. / Niewolna, M. / Chirgwin, J. M. / Guise, T. A. et al. | 2011
- S20
-
Patients with bone metastases from solid tumours and poor prognostic features may gain survival benefits from zoledronic acidBody*, J. / Cook, R. / Costa, L. / Brown, J. / Terpos, E. / Saad, F. / Lipton, A. / Coleman, R. et al. | 2011
- S22
-
An observational prospective cohort study on the dose effect of zoledronic acid on urinary n-telopeptide levels in metastatic prostate cancerDrudge-Coates*, L. / Brown, C. / Sherwood, R. / Thompson, P. M. / Muir, G. H. et al. | 2011
- S23
-
Efficacy of zoledronic acid in patients with colorectal cancer metastatic to boneSantini*, D. / Loupakis, F. / Berardi, R. / Badalamenti, G. / Addeo, L. / Ortega, C. / Sabbatini, R. / Venditti, O. / Virzi, V. / Vincenzi, B. et al. | 2011
- S25
-
Expression of matrix metalloproteinase 1 (MMP1) and dickkopf-1 (DKK1) in bone metastatic tissue (BMT) and in serum of patients with bone metastases (BM) from different solid tumorsCosta, L. / Luis*, I. / Alho, I. / Fernandes, A. / Casimiro, S. / Lee, B. H. / Gangolli, E. A. / Motwani, M. / Wang, L. / Modur, V. et al. | 2011
- S27
-
Hypocalcemia in multiple myeloma secondary to unrecognised vitamin D deficiency: A case reportRamasamy*, I. et al. | 2011
- S28
-
Metastatic bone disease of the mandible - A case reportDrozdzowska*, B. / Raczkowska-Siostrzonek, A. / Koszowski, R. et al. | 2011
- S29
-
Gene expression in prostate cancer bone metastases in relation to expression of the androgen receptor and one of its constitutively active variantsHornberg*, E. / Bergh, A. / Widmark, A. / Antti, H. / Wikstrom, P. et al. | 2011
- S30
-
The addition of zoledronic acid to combination chemotherapy decreases circulating serum levels of vascular endothelial growth factor (VEGF) in early breast cancerWinter*, M. C. / Evans, A. / Holen, I. / Coleman, R. E. et al. | 2011
- S32
-
CCN3 impairs osteoblasts and stimulates osteoclast differentiation to favor breast cancer metastasis to boneAmir*, E. / Ouellet, V. / Mourskaia, A. / Tiedemann, K. / Fong, J. / Tran-Tanh, D. / Clemons, M. / Perbal, B. / Komorova, S. / Siegel, P. et al. | 2011
- S33
-
A study of the role of twist in migration and invasion of breast cancer cellsLi, S. / Kendall, S. E. / Raices, R. / Tran, C. / Liu, Z. / Covarrubias, M. / Leigh, V. K. / Flanagan, S. D. / Glackin*, C. A. et al. | 2011
- S34
-
RANKL silencing by siRNA improves therapeutic response of primary osteosarcoma to conventional chemotherapyRousseau, J. / Escriou, V. / Lamoureux, F. / Brion, R. / Battaglia, S. / Scherman, D. / Heymann, D. / Redini*, F. / Trichet, V. et al. | 2011
- S35
-
Influence of pre-treatment with bisphosphonate on the outcome of photodynamic therapy on breast cancer metastases in murine vertebraeAkens*, M. K. / Wise-Milestone, L. / Won, E. / Wilson, B. C. / Yee, A. J. / Whyne, C. M. et al. | 2011
- S36
-
The novel anti-resorptive agent reveromycin A ameliorates bone destruction and tumor growth in myelomaWatanabe*, K. / Abe, M. / Qu, C. / Kawatani, M. / Hiasa, M. / Nakano, A. / Harada, T. / Nakamura, S. / Miki, H. / Kagawa, K. et al. | 2011
- S37
-
Targeting TCF transcriptional activity rescues syndecan-2 expression and re-sensitizes human osteosarcoma cells and mouse bone tumours to doxorubicinDieudonne*, F. X. / Marion, A. / Marie, P. J. / Modrowski, D. et al. | 2011
- S38
-
Accelerated osteolytic metastasis in B16-inoculated mice pre-exposed to non-skeletal focal irradiation in the abdomenFu, Q. / Hennings, L. / Gaddy, D. / Corry, P. M. / Jia*, D. et al. | 2011
- S39
-
Interaction of autotaxin with breast cancer cell integrins might contribute to lysophosphatidic acid-mediated bone metastasesDavid, M. / Leblanc, R. / Deux, B. / Serre, C. M. / Ribeiro, J. / Clezardin, P. / Peyruchaud*, O. et al. | 2011
- S40
-
Changes in osteoblast and osteoclast number rely on direct contact with breast cancer cells - Evidence from a longitudinal study of bone metastasisBrown*, H. K. / Ottewell, P. D. / Evans, C. A. / Holen, I. et al. | 2011
- S41
-
CpG-ODN inhibits Smad-dependent BMP signaling; Effects on myeloma cell apoptosis and in vitro osteoblastogenesisNorgaard, N. / Holien, T. / Jonsson, S. / Hella, H. / Espevik, T. / Sundan, A. / Standal*, T. et al. | 2011
- S42
-
An exopolysaccharide produced by alteromonas infernus reduces lung metastasis and prolongs survival rate of osteosarcoma-bearing miceRuiz Velasco*, C. / Colliec-Jouault, S. / Sinquin, C. / Heymann, D. / Padrines, M. et al. | 2011
- S43
-
Inhibition of Dickkopf-1 (DKK-1) delays prostate cancer growth in vivo through induction of P21CIP-1Hall*, C. L. / Zhang, H. / Baile, S. / Kuhstoss, S. / Keller, E. T. et al. | 2011
- S45
-
The homing of prostate cancer to bone in vivo is modulated by Zoledronic acidReeves*, K. J. / Cecchini, M. G. / van der Pluijm, G. / Eaton, C. L. / Hamdy, F. C. / Brown, N. J. et al. | 2011
- S46
-
Spontaneous fusion between prostate cancer cells: A driver for development of tumor heterogeneity and growth in bonePesce*, G. / Glen, A. / Lippitt, J. / Fowles, A. / Rehman, I. / Eaton, C. L. et al. | 2011
- S47
-
Twist 1 expression in an osteotropic breast cancer cell line promotes bone metastasis formation in mouseCroset*, M. / Goehrig, D. / Bonnelye, E. / Ansieau, S. / Puisieux, A. / Clezardin, P. et al. | 2011
- S48
-
Inhibition of discoidin domain receptor-1 (DDR1) impairs tumor-induced osteoclastogenesis preventing bone metastatic homing and colonizationValencia*, K. / Zandueta, C. / Ormazabal, C. / Luis-Ravelo, D. / Anton, I. / Martinez, S. / Lecanda, F. et al. | 2011
- S49
-
A method to follow tumor growth and tumor induced bone loss simultaneously over time, in vivo, using whole body bioluminescence fluorescence imagingSnoeks*, T. J. / Khmelinskii, A. / Que, I. / Lelieveldt, B. / Kaijzel, E. L. / Lowik, C. W. et al. | 2011
- S50
-
Development of a targeted strategy for enrichment and detection of calcium-binding proteins as potential biomarkers for bone metastases in breast cancerWood*, S. L. / Westbrook, J. A. / Peng, J. / Selby, P. J. / Brown, J. E. et al. | 2011
- S51
-
Breast cancer cell epidermal growth factor receptor signaling and osteolysisNickerson*, N. K. / Gilmore, J. L. / Robling, A. / Foley, J. et al. | 2011
- S54
-
Immune interplay between osteolytic disease and bone metastasisMonteiro, A. C. / Salvador, P. / Terra Mercadante, A. C. / Alves, A. P. / Balduino, A. / Duarte, M. E. / Bonomo*, A. et al. | 2011
-
The search for metastatic founder cells: Molecular analysis of disseminated tumour cells from bone marrow of cancer patientsKlein, C. A. et al. | 2011
-
Modeling the metastatic microenvironment in bone - A single niche for hematopoietic stem cells and cancer provided by skeletal progenitorsBianco, P. et al. | 2011
-
Human bone marrow-derived mesenchymal stem cell homing to orthotopic breast cancer tumors and promotion of bone metastasisReagan*, M. R. / Goldstein, R. / Rosenblatt, M. / Kaplan, D. L. et al. | 2011
-
First evidence for anti-tumour effects of doxorubicin and zoledronic acid from an immunocompetent mouse modelOttewell*, P. D. / Brown, H. / Evans, C. A. / Wind, N. S. / Brown, N. J. / Coleman, R. E. / Holen, I. et al. | 2011
-
The causal role of the BMP signalling antagonist noggin in suppressing bone formation in osteolytic bone metastasisSecondini*, C. / Wetterwald, A. / Schwaninger, R. / Thalmann, G. N. / Cecchini, M. G. et al. | 2011
-
Zoledronic acid induces IPP accumulation and release from human cancer cells, which activates Vg9Vd2 T cell-differentiation and migration in vitro and mediates Vg9Vd2 T cell-induced cancer cell death in vivoBenzaid*, I. / Monkkonen, H. / Stresing, V. / Bonnelye, E. / Green, J. / Monkkonen, J. / Clezardin, P. et al. | 2011
-
A new B Crosslaps(R) (CTX-I) assay on the IDS-ISYS automated analyserSeres*, Z. / Middlemist, S. / Dixon, C. / Laurie, D. / Barnes, A. K. / Garrity, M. et al. | 2011
-
Osteocyte-derived FGF23 activates EGR-1 signaling in prostate cancer cells: A new vicious cycle in bone metastasesFournier, P. / Edwards, D. / White, K. / Chirgwin*, J. M. et al. | 2011
-
High-dose antioxidants as potential anti-osteolytic and palliative therapies for breast cancer bone metastasisPfister, W. / Blick, T. / Kok, S. F. / Polekhina, G. / Waltham*, M. et al. | 2011
-
Quiescent stem cells in intestinal homeostasis, inflammation, and cancerFodde, R. et al. | 2011
-
62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancerGnant*, M. / Mlineritsch, B. / Stoeger, H. / Luschin-Ebengreuth, G. / Poestlberger, S. / Steger, G. / Jakesz, R. / Singer, C. / Eidtmann, H. / Greil, R. et al. | 2011
-
A multicenter prospective study of the risk factors affecting bone mineral density in Korean patients with prostate cancerJung, S. I. / Kim, S. O. / Kang*, T. W. / Kwon, D. D. / Park, J. Y. / Cheon, J. / Lee, H. M. / Hong, S. J. / Choi, H. Y. / Ryu, S. B. et al. | 2011
-
Cathepsin K inhibitors for the treatment of bone metastasisLindstrom*, E. / Vrang, L. / Sedig, S. / Terelius, Y. / Sahlberg, B. L. / Wikstrom, K. / Samuelsson, B. / Chambers, T. / Grabowska, U. et al. | 2011
-
The Italian cross-sectional survey on the management of bone health in oncology: The ZETA study (On Behalf of ZETA Study Group)Bertoldo*, F. / Santini, D. / Cecchini, I. / Bartolussi, P. / Fregosi, S. et al. | 2011
-
Reduced risk of breast cancer in postmenopausal women with osteoporosis. Preliminary results in a high risk metropolitan area: A case-control studyLumachi*, F. / Tombolan, V. / Camozzi, V. / Luisetto, G. / Basso, S. M. / Brunello, A. / Basso, U. et al. | 2011
-
Identification of hydrogen sulfide releasing compounds as novel antiresorptive and antitumour agentsIdris*, A. I. / Frantzias, J. / Mollat, P. / Sparatore, A. / Del Soldato, P. / Ralston, S. H. et al. | 2011
-
GLPG0187 inhibits progression of established bone metastasis and achieves maximum efficacy when combined with standard-of-care metastatic breast cancer treatmentsClement-Lacroix, P. / Berrocal, E. / Heckmann, B. / Wigerinck, P. / Lorenzon, G. / Pujuguet*, P. et al. | 2011
-
The role of parathyroid hormone-related protein in giant cell tumour of boneCowan*, R. W. / Singh, G. / Ghert, M. et al. | 2011
-
Effect of VEGF inhibitor PF-00337219 and FAK/PYK2 inhibitor PF-562,271 on intratibial growth of breast cancer cells in nude rats and miceBagi*, C. M. / Pero, R. / Berryman, E. / Aupi, D. / Wilkie, D. / Andresen, C. J. et al. | 2011
-
10th International Conference on Cancer Induced Bone Disease| 2011
-
Denosumab decreases proliferation in giant cell tumor of bone (GCTB)Roudier, M. / Blay*, J. Y. / Chawla, S. / Manivel, C. / Nelson, S. D. / Thomas, D. / Woody, L. / Soriano, R. / Jun, S. / Jacobs, I. et al. | 2011
-
First randomized trial comparing balloon kyphoplasty (BKP) to non-surgical management among cancer patients with vertebral compression fracturesBastian*, L. / Pflugmacher, R. / Berenson, J. R. / Jarzem, P. / Zonder, J. / Tillman, J. B. / Ashraf, T. / Vrionis, F. D. et al. | 2011
-
Denosumab versus zoledronic acid (ZA) for the treatment of bone metastases: An integrated analysis of results from 2 randomized, double-blind, phase 3 trialsLipton*, A. / Stopeck, A. / von Moos, R. / Henry, D. / Richardson, G. / Rodriguez, G. / Bourgeois, H. / Ke, C. / Jun, S. / Dansey, R. et al. | 2011
-
Glutamate release in bone metastasisSeidlitz*, E. P. / Sharma, M. K. / Singh, G. et al. | 2011
-
Towards biomarkers of bone-metastasis using cellular proteomicsWestbrook*, J. A. / Peng, J. / Cairns, D. A. / Ottewell, P. D. / Holen, I. / Coleman, R. E. / Selby, P. J. / Banks, R. E. / Brown, J. E. et al. | 2011
-
Controlled skeletal tissue ablation using novel navigational radio frequence ablation deviceKurth*, A. A. / Proschek, D. / Germain, A. / Poser, R. et al. | 2011
-
Combination vs single agent treatment: The effects of zoledronic acid+/-doxorubicin on breast tumour growth in bone prior to development of osteolytic bone diseaseBrown*, H. K. / Ottewell, P. D. / Evans, C. A. / Coleman, R. E. / Holen, I. et al. | 2011
-
Risk of osteonecrosis of the jaw and the use of bone targeted therapiesRuggiero, S. L. et al. | 2011
-
Experimental study of specific antitumor immunity induced by dendritic cell vaccine transfected with tumor cell total RNA in Ewing's sarcoma patientsSang*, H. X. / Wang, J. / Wang, L. / Wang, Z. / Lu, B. / Fan, Y. / Zhu, W. J. et al. | 2011
-
Exploiting the tear proteome for the diagnosis of breast cancerWasham, C. / Byrum, S. / Bhattacharyya, S. / Klimberg, V. S. / Suva*, L. J. et al. | 2011
-
Analysis of the various components of bone turnover in postmenopausal breast cancer patients with bone metastasesBertoldo*, F. / Pancheri, S. / Boldini, S. / Zenari, S. / Avesani, A. et al. | 2011
-
The role of pamidronate in palliative treatment for bone metastases in squamous cell carcinoma of head and neckRolski*, W. / Leppert, W. et al. | 2011
-
Breast carcinoma cells modulate main characteristics and functional properties of human bone marrow-derived mesenchymal stromal cells in a non-contact dependent mannerWobus*, M. / Dittrich, T. / Hofbauer, L. / Ehninger, G. / Bornhauser, M. et al. | 2011
-
New therapies for cancer induced bone disease: Clinical perspectiveVan Poznak, C. et al. | 2011
-
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE-BIG 01-04) for women with stage II/III breast cancerColeman, R. E. / Woodward*, E. J. / Brown, J. E. / Cameron, D. / Bell, R. / Dodwell, D. / Keane, M. / Gil, M. / Davies, C. / Burkinshaw, R. et al. | 2011
-
Osteolytic versus mixed osteolytic/osteoblastic vertebral metastasis: Comparison of bone structural and remodelling properties in two preclinical rat modelsWise-Milestone*, L. / Akens, M. K. / Thudi, N. K. / Rosol, T. J. / Grynpas, M. D. / Yee, A. / Wilson, B. / Whyne, C. M. et al. | 2011
-
A direct contact model system to study tumor cell-bone cell interactions in prostate cancer bone metastasesNordstrand*, A. / Wikstrom, P. / Lerner, U. H. / Widmark, A. et al. | 2011
-
Molecular characterization of the stromal response to osteoblastic bone metastasis by tissue-compartment specific transcriptional profilingOzdemir*, B. / Secondini, C. / Wetterwald, A. / Schwaninger, R. / Raffelsberger, W. / Poch, O. / Delorenzi, M. / van der Pluijm, G. / Thalmann, G. N. / Cecchini, M. G. et al. | 2011
-
RAP-661 treatment, an ALK3 (BMPRIA) antagonist, decreases rankl and regulates osteoclastogenesisSolban*, N. / Cornwall-Brady, M. / Kawamoto, Y. / Underwood, K. W. / Kumar, R. / Seehra, J. / Canalis, E. / Pearsall, R. S. et al. | 2011
-
New anabolic approaches to treating myeloma bone diseaseRoodman, G. et al. | 2011
-
Targeting tumour-initiating cells with trail based combination therapy ensures complete and lasting eradication of multiple myeloma tumours in vivoVitovski*, S. / Chantry, A. D. / Lawson, M. A. / Croucher, P. I. et al. | 2011
-
Natural history of malignant bone disease in colorectal cancer: Final results of a large Italian ''bone metastases'' surveySantini*, D. / Barni, S. / Tampellini, M. / Silvestris, N. / Maiello, E. / Calipari, N. / Ibrahim, T. / Catalano, V. / Vincenzi, B. / Tonini, G. et al. | 2011
-
One year effect of anastrozole and risedronate on bone mineral density: First results from the IBIS-II bone sub-studySingh*, S. / Cuzick, J. / Blake, G. M. / Mesher, D. / Patel, R. / Truscott, J. / Coleman, R. / Howell, A. / Forbes, J. / Eastell, R. et al. | 2011
-
Comparing early intervention with zoledronic acid to no bisphosphonate (BP) therapy in patients with metastatic prostate cancer to bone: A study of the US Veterans Affairs (VA) populationWu*, E. Q. / Guo, A. / Shi, L. / Lu, M. / Yu, A. P. / Sharma, H. / Fan, C. P. / Velde, N. V. et al. | 2011
-
Activation of the osteopontin gene, a bone metastatic signature, by transcription factor ERG in prostatic cancer cellsFlajollet, S. / Tian, T. V. / Flourens, A. / Tomavo, N. / Bonnelye, E. / Leroy, X. / Duterque-Coquillaud*, M. et al. | 2011
-
Direct anti-cancer effect of oncostatin M on chondrosarcomaDavid, E. / Guihard, P. / Brounais, B. / Riet, A. / Charrier, C. / Battaglia, S. / Ponsolle, S. / Le Bot, R. / Richards, C. D. / Heymann, D. et al. | 2011
-
TGFb target gene NEDD9 identified by gene profiling plays a critical role in breast cancer bone metastasisHata*, K. / Morita, Y. / Nakanishi, M. / Nishisyou, T. / Yoneda, T. et al. | 2011
-
Multiphoton imaging of individual myeloma cells in calvariae: Association of myeloma development with sites of bone turnoverWilliams*, A. J. / Lawson, M. A. / Alamer, O. / Hough, J. / Bos, T. / Vanderkerken, K. / Croucher, P. I. et al. | 2011
-
A phase II, randomized, open-label, pilot study to evaluate the safety and the effects on bone resorption of saracatinib (AZD0530) in patients with prostate cancer or breast cancer with metastatic bone diseaseAklilu*, M. / Hussain, A. / Evans, C. P. / Hannon, R. A. / Lipton, A. / Dimairo, M. / Yu, J. / Zobel, P. / Torti, F. M. / Finkelman, R. D. et al. | 2011
-
Bone mineral density and bone remodelling markers osteocalcin and alkaline phosphatase in patients with Stage IV breast cancerLumachi*, F. / Camozzi, V. / Luisetto, G. / Orlando, R. / Basso, S. M. / Brunello, A. / Basso, U. et al. | 2011
-
Rapid pain reduction following loading-dose ibandronate in bone metastasesKurth*, A. A. / Muller, A. / Habermann, B. / Eberhardt, C. et al. | 2011
-
The chemokine receptor CXCR7 is highly expressed in bone metastatic lesions of human prostate cancer and mediates tumor cell growth and invasiveness in preclinical modelsGravina, G. L. / Angelini, M. / Montironi, R. / Ventura, L. / Marampon, F. / Pratesi, G. / Tortoreto, M. / Tombolini, V. / Festuccia*, C. et al. | 2011
-
Camp-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destructionSon, J. / Lee, J. H. / Kim, H. N. / Ha, H. / Lee*, Z. H. et al. | 2011
-
Skeletal rigidity enhances TGF-B effects on cancer cell expression of osteolytic factorsRuppender, N. S. / Sterling*, J. A. / Martin, T. J. / Mundy, G. R. / Guelcher, S. A. et al. | 2011
-
The role of fibronectin originating from different sources on breast cancer metastasis development and bone remodelingvon Au, A. / Vasel, M. / Cecchini, M. / Nakchbandi*, I. A. et al. | 2011
-
Calcium metabolism in castration-resistant prostate cancer patients: Development of a quantitative urinary assay for extent of bone metastasisHillegonds*, D. J. / Pan, C. X. / Lara, P. N. et al. | 2011
-
Role of macrophages in tumour progression and therapyLewis, C. E. et al. | 2011
-
Cell trafficking in multiple myelomaGhobrial, I. et al. | 2011
-
Involvement of acidic microenvironment in bone pain associated with cancer colonizationYoneda, T. / Nakanishi, M. / Nishisho, T. / Wakabayashi, H. / Hata, K. et al. | 2011
-
Lessons to be learned from osteosarcomaHeymann, D. et al. | 2011
-
Tumour-secreted lox mediates osteolytic bone metastases prior to metastatic tumour cell colonisationEvans, H. R. / Ab Latif, N. / Cox, T. R. / Bird, D. / Lang, G. / Erler, J. T. / Gartland*, A. et al. | 2011
-
Adjuvant effect of IV clodronate on delay of bone metastasis in high-risk prostate cancer patientsRodrigues^@?, P. / Hering, F. et al. | 2011
-
Relationship between serum N-telopeptide and bone alkaline phosphatase and their diagnostic value in patients with breast cancer and bone metastasesLumachi@?, F. / Camozzi, V. / Luisetto, G. / Orlando, R. / Basso, S. M. / Basso, U. / Cappelletti, P. et al. | 2011
-
Prospective clinical trial to evaluate the value of radiofrequence ablation and cement augmentation of spinal metastasesProschek, D. / Habermann, B. / Tonak, M. / Proschek, P. / Kurth*, A. A. et al. | 2011
-
Peripheral cannabinoid type 2 receptor regulates osteoclast formation, MDA-MB-231 breast cancer cell migration and bone marrow/tumour cell interaction via PI3 kinase/AKT and P38 pathwaysSophocleous*, A. / Mackintosh, A. / Landao-Bassonga, E. / Ralston, S. H. / Idris, A. I. et al. | 2011
-
Molecular beacon-guided surgical resection of primary spinal neoplasmsLiu*, T. W. / Akens, M. / Chen, J. / Wise-Milestone, L. / Wilson, B. C. / Zheng, G. et al. | 2011
-
Surgical resection of isolated breast cancer recurrence within the sternumCrighton*, J. / Hall, P. / Lord, S. / Perrin, T. / Dodwell, D. et al. | 2011
-
Bone health in breast cancer survivors following adjuvant bisphosphonate therapy: AZURE quantitative bone scan sub-studyWoodward*, E. J. / Brown, J. E. / Barnfield, M. C. / Taylor, J. / Blake, G. M. / Fogelman, I. / Turner, L. A. / Thorpe, H. / Dodwell, D. / Joffe, J. K. et al. | 2011
-
Osteoprotegerin inhibitits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL produced by tumor cellsPicarda, G. / Matous, E. / Hervouet, S. / Lamoureux, F. / Trichet, V. / Heymann, D. / Redini, F. et al. | 2011
-
Local treatment of mixed osteolytic/osteoblastic spinal metastases: Is photodynamic therapy effective?Wise-Milestone*, L. / Akens, M. K. / Thudi, N. K. / Rosol, T. J. / Grynpas, M. D. / Yee, A. / Wilson, B. / Whyne, C. M. et al. | 2011
-
Abnormal expression of calpain-6 due to endothelin-1/NFkB signalling contributes to cell survival and chemoresistance in osteosarcoma cellsMarion*, A. / Dieudonne, F. X. / Patino, A. / Lecanda, F. / Marie, P. J. / Modrowski, D. et al. | 2011
-
Examination of the mechanism(s) of cancer-induced bone pain in animal modelsUngard*, R. / Seidlitz, E. / De Ciantis, P. / Yashpal, K. / Henry, J. L. / Singh, G. et al. | 2011
-
Comparison of optical, radiography and micro-Computed Tomography imaging methods for the analysis of bone metastases in a murine modelTiwari*, S. / Schem, C. / Lorenzen, A. C. / Kayser, O. / Graeff, C. / Pena, J. / Marshall, R. P. / Jonat, W. / Gluer, C. C. et al. | 2011
-
MNNG-HOS osteosarcoma growth is enhanced by human fat and adipose-derived mesenchymal stem cells: Implication in reconstructive surgery following tumor treatmentBourdais, L. / Perrot, P. / Duteille, D. / Hervouet, S. / Chesneau, J. / Amiaud, J. / Picarda, G. / De Pigneux, G. / Redini, F. / Heymann*, D. et al. | 2011
-
10th International Conference on Cancer Induced Bone Disease, 22-25 September 2010, Sheffield, UK Abstracts| 2011
-
Challenges of research on circulating tumour cells in carcinoma patientsRiethdorf, S. / Pantel, K. et al. | 2011
-
Laser-capture micro-dissection and gene array analysis to identify new molecules implicated in the development of myeloma bone diseaseBuckle*, C. / Andersen, T. / Delaisse, J. M. / Vanderkerken, K. / Croucher, P. I. et al. | 2011
-
Can bone biopsies be used to confirm metastatic disease recurrence and receptor status in breast cancer patients?Amir*, E. / Miller, N. / Geddie, W. / Maung, H. / Freedman, O. C. / Oldfield, M. / Napolskikh, J. / Kassam, F. / Clemons, M. et al. | 2011
-
Mechanisms of osteoblast supression in multiple myeolmaKassen*, D. / Rabin, N. / Lath, D. / Croucher, P. I. / Yong, K. et al. | 2011
-
Artificial niches that direct stem cell fateLutolf, M. P. et al. | 2011
-
Cancer and the evolution of stem cell fatesAndrews, P. W. et al. | 2011
-
Denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer: Results from a phase 3 randomized trialBrown*, J. / Carducci, M. / Fizazi, K. / Smith, M. / Damiao, R. / Karsh, L. / Milecki, P. / Wang, H. / Dansey, R. / Goessl, C. et al. | 2011
-
The role of macrophage stimulating protein in metastasis of breast cancer to boneKretschmann*, K. / Waltz, S. E. / Welm, A. L. et al. | 2011
-
TIMP-3 up-regulation facilitates osteoclastogenesis and suppresses DC differentiation from monocytes in the bone marrow microenvironment in myelomaAbe*, M. / Hiasa, M. / Nakano, A. / Nakamura, S. / Miki, H. / Qu, C. / Watanabe, K. / Harada, T. / Kagawa, K. / Takeuchi, K. et al. | 2011
-
Novel application of aptamer selection (pheno-SELEX) to target the invasive phenotype successfully creates anti-metastatic aptamersShelley*, G. / Zhang, X. / Keller, J. / Keller, E. et al. | 2011
-
Probing the relationship between breast cancer stem cells and bone metastasisTan-Allen, K. / Gilmore, J. E. / Foley, J. et al. | 2011
-
The novel and selective insulin-like growth factor-1 receptor kinase inhibitor PQIP suppresses bone cell function and osteoclast-breast cancer cell cross-talk in vitroLogan*, J. G. / Landao-Bassonga, E. / Brunton, V. G. / Idris, A. I. et al. | 2011
-
Does differential expression of CD151 affect the ability of beast cancer cells to establish tumours in bone?Wind*, N. S. / Brown, H. / Ottewell, P. D. / Sadej, R. / Romanska, H. / Berditchevski, F. / Holen, I. et al. | 2011
-
Corning osteo assay surface for the study of bone resorptionFaruqi*, A. F. / Rao, H. / Causer, J. / Beltzer, J. et al. | 2011
-
Evaluation of a novel bone targeted aracytidine therapy in dogs with spontaneous osteosarcomaZinnen*, S. / Thamm, D. / Vail, D. / Fan, T. / Karpeisky, A. et al. | 2011
-
Improved methods for 3D SEM imaging of cancellous bone in metastatic cancers in boneBoyde*, A. / Harland, S. et al. | 2011
-
Prostate cancer-derived exosomes down-modulate NKG2D expression in immune effector cellsLundholm*, M. / Wikstrom, P. et al. | 2011